STRUCTURE,STRUCTURE_ID,STRUCTURE_NAME,ACTION,REF_AREA,Reference area,FREQ,Frequency of observation,MEASURE,Measure,UNIT_MEASURE,Unit of measure,FINANCING_SCHEME,Financing scheme,FINANCING_SCHEME_REV,Revenues of financing schemes,FUNCTION,Health function,MODE_PROVISION,Mode of provision,PROVIDER,Health care provider,FACTOR_PROVISION,Factor of provision,ASSET_TYPE,Asset type,PRICE_BASE,Price base,TIME_PERIOD,Time period,OBS_VALUE,Observation value,BASE_PER,Base period,CURRENCY,Currency,OBS_STATUS,Observation status,OBS_STATUS2,Observation status 2,OBS_STATUS3,Observation status 3,UNIT_MULT,Unit multiplier,DECIMALS,Decimals
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,539.844,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,32.055,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,5.511,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,7149.63,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,POL,Poland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,1717.584,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,903.853,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,0.542,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,2.359,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,5.171,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,2238.946,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,1108.133,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,3968.391,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,40.944,,,,,,D,Definition differs,P,Provisional value,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,0.083,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FIN,Finland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,27.519,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,148.048,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,540.997,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,0.214,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,0.075,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,309.18,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,374.5,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,10716.355,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,11445.064,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,JPN,Japan,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,55.814,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,45.003,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,85.288,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,3.951,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,843.101,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,321.062,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,MLT,Malta,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,25.724,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,MLT,Malta,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,4.633,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,668.843,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,25.572,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,25.448,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,POL,Poland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,2217.997,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ROU,Romania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,416.343,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ROU,Romania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,677.9,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,COL,Colombia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2023,,381.007,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,COL,Colombia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,663.747,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,COL,Colombia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,2574.006,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,207.163,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,479.457,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,39.625,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,808.693,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,1108.178,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,2267.476,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,290.201,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,623.63,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,2422.267,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,8095.986,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,2207.714,,,,,,D,Definition differs,P,Provisional value,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,5.968,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,4007.645,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,1797.445,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,378.726,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2023,,477.702,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,383.135,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,1524.726,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,5422.792,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,4301.211,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,576.917,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,1827.028,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,607.635,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,3.263,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,755.885,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,299.659,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,3759.152,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,19.619,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,114.763,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,24.349,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,135.74,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,15.688,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,15.092,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2023,,88.055,,2015,,,,D,Definition differs,P,Provisional value,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,1.634,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,82.437,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,107.641,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,0.442,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,1.902,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,32.695,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,35.533,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,4524.738,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,1961.064,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,398.506,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2023,,547.743,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,696.915,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,1066.794,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,3519.992,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,569.928,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,3395.738,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,SWE,Sweden,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,194.908,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,SWE,Sweden,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,307.128,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,COL,Colombia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,890.066,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,COL,Colombia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,3119.903,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,COL,Colombia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2023,,525.935,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,39.712,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,30.259,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,66.175,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,112.502,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,212.944,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,143.744,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,929.405,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,175.001,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,0.17,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,47.739,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2023,,6.985,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,75.299,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,233.388,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,569.977,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,17.244,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,205.793,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,375.975,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,279.7,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GRC,Greece,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,888.742,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GRC,Greece,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,606.542,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,42.457,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,154.831,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,336.703,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,692.395,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,134.415,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,162.309,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FIN,Finland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,0.207,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,763.281,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,4245.819,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,355.928,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,1907.234,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,1532.857,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,1463.371,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,1.953,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,29.703,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,21.135,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,5.046,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,COL,Colombia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,400.77,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,COL,Colombia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,1159.806,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,667.351,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,4145.495,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,4766.794,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,666.822,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,2115.219,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FIN,Finland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,0.241,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,SWE,Sweden,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,147.165,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,SWE,Sweden,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,253.314,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,6.709,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,15.579,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,POL,Poland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,0.521,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,6494.063,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,3449.113,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2023,,918.057,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,45.906,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,88.059,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,11.675,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FIN,Finland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,32.074,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,900.088,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,5195.996,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,5789.693,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,IRL,Ireland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,398.433,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,IRL,Ireland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,544.17,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,484.351,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,2369.333,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,806.403,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,0.199,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,28.522,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,5.561,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,13.645,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,6.619,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,39.884,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,63.934,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,299.784,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,2.173,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,42.151,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,42.156,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,COL,Colombia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,537.421,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,COL,Colombia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,1405.778,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,119.738,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,186.657,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,240.946,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,270.011,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,17.952,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,1.431,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,7.401,,2015,,,,D,Definition differs,P,Provisional value,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,55.104,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,30.427,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,82.894,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,61.933,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,484.856,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,831.955,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,619.196,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,712.622,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,1855.889,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,728.774,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,8883.402,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,10023.971,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,801.045,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,157.621,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,JPN,Japan,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,306.626,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,56.046,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,184.146,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,JPN,Japan,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,56.438,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,MLT,Malta,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,15.397,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,MLT,Malta,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,53.11,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,POL,Poland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,978.777,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,2.24,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,6.928,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,30.314,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,27.001,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,76.372,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,61.683,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2023,,0.482,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,0.177,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,0.068,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,1881.228,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,6.799,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,0.417,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,5.473,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,4.783,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FIN,Finland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,23.956,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,7.967,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,16.751,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,3.867,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,7.039,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,9.804,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,0.692,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,2.8,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,5.868,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,170.757,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,155.387,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,269.278,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,JPN,Japan,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,303.239,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,243.019,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,75.559,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,102.298,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GBR,United Kingdom,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,3817.546,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GBR,United Kingdom,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,9160.447,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GBR,United Kingdom,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,100.654,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,12.274,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,12.717,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,MLT,Malta,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,7.816,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,MLT,Malta,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,6.874,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FIN,Finland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,56.545,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,194.712,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,68.869,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,93.918,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,111.397,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,175.154,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,2.885,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,12.186,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,91.087,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,150.173,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,202.494,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,1480.801,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,0.262,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,0.07,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2023,,124.473,,,,,,D,Definition differs,P,Provisional value,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,JPN,Japan,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,468.097,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,7.773,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,274.375,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,23.744,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,POL,Poland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,6434.56,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,7903.645,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,10489.958,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,2155.265,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,64.446,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,1347.055,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,1324.254,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2023,,13.179,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,6.707,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,0.648,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,8.23,,2015,,,,D,Definition differs,P,Provisional value,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GBR,United Kingdom,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,83.092,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GBR,United Kingdom,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,2943.651,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GBR,United Kingdom,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,7484.124,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,3.588,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,10296.54,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,8114.523,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2023,,1381.947,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,2971.935,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,291.703,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,2079.74,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GRC,Greece,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,517.238,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GRC,Greece,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,699.35,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,1710.487,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,8862.774,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,6986.224,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,4034.296,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,4898.546,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,50.373,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,MLT,Malta,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,19.235,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,MLT,Malta,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,59.848,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,5.039,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,8.445,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,11.305,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,84.585,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,47.128,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,34.337,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,13759.29,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,10031.105,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,4.272,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2023,,1953.489,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,177.541,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,458.57,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,14.492,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,100.982,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,106.992,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,34.238,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,516.713,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,851.115,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,2898.094,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,28.822,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,73.112,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,84.609,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,0.326,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,4.684,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,4.178,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2023,,320.7,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,1445.648,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,637.625,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,1052.284,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,0.014,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,652.534,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,3.381,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,90.465,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,2.32,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,34.417,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,76.174,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,0.226,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GBR,United Kingdom,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,2953.874,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GBR,United Kingdom,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,517.744,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,13.365,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,58.826,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,102.877,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GBR,United Kingdom,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,2277.686,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,GBR,United Kingdom,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,422.999,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,659.656,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,1034.783,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,737.12,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,28.377,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,8.748,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,147.252,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,0.202,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,8.073,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,33.074,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,5027.764,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,6.425,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,282.122,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,678.641,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,790.846,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,2.383,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,10.925,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NOR,Norway,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,60.964,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NOR,Norway,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,183.946,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HUN,Hungary,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,1128.907,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,1560.446,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,656.36,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,1100.243,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,1378.349,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,2699.311,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,MLT,Malta,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,20.591,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,MLT,Malta,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,4.112,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,IRL,Ireland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,482.266,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,IRL,Ireland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,320.927,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,1654.26,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,2507.094,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,212.745,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,421.938,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,807.856,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,1.21,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,415.158,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,872.163,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,372.474,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,201.423,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BEL,Belgium,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,672.891,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,272.866,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,582.305,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,46.543,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,3894.14,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,7085.208,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,0.11,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2023,,1052.663,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,2269.39,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,7.763,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,279.29,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,351.26,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ROU,Romania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,604.718,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ROU,Romania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,893.746,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,917.074,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,1013.812,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,0.236,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,899.375,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FRA,France,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,2651.233,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,42.347,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,JPN,Japan,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,1209.578,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,26.858,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,65.202,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,0.198,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,21.803,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,1.884,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,8.694,,,,,,D,Definition differs,P,Provisional value,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,POL,Poland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,0.403,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,322.517,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,268.165,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,0.768,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,10.61,,,,,,D,Definition differs,P,Provisional value,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,7.664,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,451.034,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,237.174,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,1.125,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,107.209,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,8.738,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,47.435,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HRV,Croatia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,0.576,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,19.424,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,10.009,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,598.184,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,919.263,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,798.05,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2023,,299.853,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,COL,Colombia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,230.529,,,,,,B,Time series break,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,JPN,Japan,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,1196.217,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FIN,Finland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,48.515,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,55.861,,2015,,,,B,Time series break,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,788.233,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,24.283,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,36.876,,2015,,,,D,Definition differs,P,Provisional value,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,1226.64,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,916.222,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NOR,Norway,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,230.574,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NOR,Norway,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,83.152,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,785.074,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,2269.694,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,0.3,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,0.09,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,0.099,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,4276.96,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,4905.691,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,2665.596,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,787.387,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISR,Israel,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,878.048,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,HUN,Hungary,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,975.113,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,123.461,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,138.461,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DNK,Denmark,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,81.946,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,2.489,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,72.894,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,1.961,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,70.954,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,EST,Estonia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,54.102,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,1949.65,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,706.848,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,548.275,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,873.635,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,KOR,Korea,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2023,,261.51,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,305.488,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,638.85,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUT,Austria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,1.019,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,1547.305,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,3613.526,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,6319.731,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,2.232,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,38.293,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CYP,Cyprus,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,25.074,,,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,6.641,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,121.244,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LVA,Latvia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,0.172,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LTU,Lithuania,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,0.149,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,JPN,Japan,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,462.926,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,MLT,Malta,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,9.764,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,MLT,Malta,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,7.746,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,95.129,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CRI,Costa Rica,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,54.491,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,POL,Poland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,4982.829,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,317.603,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ESP,Spain,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,1335.406,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,1634.273,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,AUS,Australia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,1619.982,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,FIN,Finland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,20.554,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,2046.529,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,7156.238,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CAN,Canada,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,1752.113,,2015,,,,D,Definition differs,P,Provisional value,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,305.082,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,702.062,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,NLD,Netherlands,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,314.545,,2015,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,1014.639,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,1440.865,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,1089.858,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,1081.827,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,515.798,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,883.858,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2023,,226.871,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,POL,Poland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,757.95,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,ISL,Iceland,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,8.82,,,,,,D,Definition differs,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,COL,Colombia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,195.387,,2015,,,,B,Time series break,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,0.011,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CZE,Czechia,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,550.471,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,1.449,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,CHL,Chile,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HKCOV1,COVID-19 related investment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,125.933,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,BGR,Bulgaria,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV4,COVID-19 related costs for medical goods,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,66.437,,,,,,B,Time series break,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,48.227,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,1089.681,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,1112.297,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,DEU,Germany,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2023,,9.323,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2022,,37.997,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2021,,64.935,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2020,,0.152,,2015,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV3,COVID-19 related costs for vaccination,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,Q,Constant prices,2023,,5.308,,2015,,,,P,Provisional value,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2020,,68.783,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2022,,33.924,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2021,,88.561,,,,,,,,,,,,6,Millions,1,One
DATAFLOW,OECD.ELS.HD:DSD_SHA@DF_SHA(1.0),Health expenditure and financing,I,LUX,Luxembourg,A,Annual,EXP_HEALTH,Expenditure,USD_PPP,"US dollars, PPP converted",_T,Total,_Z,Not application,HCCOV1,COVID-19 related treatment costs,_T,Total,_T,Total,_Z,Not applicable,_Z,Not applicable,V,Current prices,2023,,0.634,,,,,,P,Provisional value,,,,,6,Millions,1,One
